Your browser doesn't support javascript.
loading
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial.
Rohaan, M W; Gomez-Eerland, R; van den Berg, J H; Geukes Foppen, M H; van Zon, M; Raud, B; Jedema, I; Scheij, S; de Boer, R; Bakker, N A M; van den Broek, D; Pronk, L M; Grijpink-Ongering, L G; Sari, A; Kessels, R; van den Haak, M; Mallo, H A; Karger, M; van de Wiel, B A; Zuur, C L; Duinkerken, C W; Lalezari, F; van Thienen, J V; Wilgenhof, S; Blank, C U; Beijnen, J H; Nuijen, B; Schumacher, T N; Haanen, J B A G.
Affiliation
  • Rohaan MW; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Gomez-Eerland R; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van den Berg JH; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Geukes Foppen MH; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Zon M; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Raud B; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Jedema I; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Scheij S; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Boer R; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bakker NAM; Biotherapeutics Unit, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Pronk LM; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Grijpink-Ongering LG; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Sari A; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kessels R; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van den Haak M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mallo HA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Karger M; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van de Wiel BA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Zuur CL; Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Duinkerken CW; Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lalezari F; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Thienen JV; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wilgenhof S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nuijen B; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schumacher TN; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Haanen JBAG; Oncode Institute, Utrecht, The Netherlands.
Immunooncol Technol ; 15: 100089, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35865122
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Immunooncol Technol Year: 2022 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Immunooncol Technol Year: 2022 Type: Article Affiliation country: Netherlands